Marché européen des dispositifs d’administration de médicaments – Tendances et prévisions du secteur jusqu’en 2031

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché européen des dispositifs d’administration de médicaments – Tendances et prévisions du secteur jusqu’en 2031

  • Medical Devices
  • Publish Reports
  • Aug 2024
  • Europe
  • 350 Pages
  • Nombre de tableaux : 381
  • Nombre de figures : 30

Europe Drug Delivery Devices Market

Taille du marché en milliards USD

TCAC :  % Diagram

Diagram Période de prévision
2024 –2031
Diagram Taille du marché (année de référence)
USD 497.13 Billion
Diagram Taille du marché (année de prévision)
USD 864.31 Billion
Diagram TCAC
%
DiagramPrincipaux acteurs du marché
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5 < /li>

>Marché européen des dispositifs d'administration de médicaments, par type de produit ( administration de médicaments par voie orale , administration de médicaments par voie injectable, administration de médicaments topiques, administration de médicaments ophtalmiques , administration de médicaments par voie nasale, administration de médicaments par voie pulmonaire , administration de médicaments par voie transmuqueuse et administration de médicaments implantables ), utilisateur final (hôpitaux, soins de santé à domicile, cliniques, soins de santé communautaires et autres), canal de distribution (appels d'offres directs, pharmacies hospitalières, pharmacies et pharmacies en ligne) - Tendances et prévisions de l'industrie jusqu'en 2031.

Marché européen des dispositifs d'administration de médicaments

Analyse et taille du marché des dispositifs d'administration de médicaments en Europe

Le marché européen des dispositifs d'administration de médicaments connaît une croissance significative, tirée par la prévalence croissante des maladies chroniques et non chroniques, la croissance du développement de dispositifs de médicaments biologiques et la sensibilisation croissante au diagnostic et au traitement. Le marché est caractérisé par la présence d'un grand nombre d'acteurs proposant une large gamme de dispositifs de diagnostic adaptés aux divers besoins des prestataires de soins de santé de la région.

Data Bridge Market Research analyse que le marché européen des dispositifs d'administration de médicaments croît avec un TCAC de 7,5 % au cours de la période de prévision de 2024 à 2031 et devrait atteindre 864,31 milliards USD d'ici 2031 contre 497,13 milliards USD en 2023.

Rapport métrique

Détails

Période de prévision

2024 à 2031

Année de base

2023

Année historique

2022 (Personnalisable 2016-2021)

Unités quantitatives

Chiffre d'affaires en milliards USD

Segments couverts

Type de produit (administration de médicaments par voie orale, administration de médicaments par voie injectable, administration de médicaments topiques, administration de médicaments par voie ophtalmique, administration de médicaments par voie nasale, administration de médicaments par voie pulmonaire , administration de médicaments par voie transmuqueuse et administration de médicaments implantables), utilisateur final (hôpitaux, soins de santé à domicile , cliniques, soins de santé communautaires et autres), canal de distribution (appels d'offres directs, pharmacies hospitalières, pharmacies et pharmacies en ligne)

Pays couverts

Allemagne, Royaume-Uni, Italie, France, Espagne, Russie, Suisse, Turquie, Belgique, Pays-Bas et reste de l'Europe,

Acteurs du marché couverts

BD, F. Hoffmann-La Roche Ltd, Novartis AG, Sanofi, Johnson & Johnson Services, Inc., 3M, Gerresheimer AG, Medmix, OraSure Technologies Inc., Insulet Corporation, Bayer AG, Pfizer Inc., GSK plc., Merck & Co., Inc., Amgen Inc., AbbVie Inc., Elcam Medical, SMC Ltd., ViVO Smart Medical Devices Ltd., West et Pharmaceutical Services, Inc. entre autres

Définition du marché

Les dispositifs d'administration de médicaments sont des dispositifs médicaux conçus pour administrer des médicaments à l'organisme de manière contrôlée et ciblée, améliorant ainsi leur efficacité, leur sécurité et l'observance du traitement par le patient. Ces dispositifs peuvent être externes, tels que les inhalateurs, les injecteurs et les pompes, ou internes, tels que les dispositifs implantables, et sont utilisés pour administrer une large gamme de médicaments, notamment des petites molécules, des produits biologiques et des vaccins. Ils peuvent modifier la vitesse de libération, la biodisponibilité et l'absorption des médicaments, ainsi que fournir une surveillance et un retour d'information en temps réel aux patients et aux prestataires de soins de santé. Les dispositifs d'administration de médicaments jouent un rôle crucial dans l'optimisation des résultats du traitement et l'amélioration de la qualité de vie des patients atteints de diverses maladies et affections, notamment les maladies chroniques, les maladies infectieuses et le cancer.

Dynamique du marché des dispositifs d'administration de médicaments en Europe

Cette section traite de la compréhension des moteurs, des avantages, des opportunités, des contraintes et des défis du marché. Tout cela est discuté en détail ci-dessous :

Conducteurs

  • Augmentation de la prévalence des maladies chroniques et non chroniques

La prévalence de maladies et d'affections telles que les maladies cardiovasculaires (MCV), l'asthme, le cancer, les troubles neurologiques, les accidents vasculaires cérébraux, le diabète et les maladies respiratoires a considérablement augmenté au fil du temps. Vous trouverez ci-dessous quelques-unes des statistiques importantes liées à certaines maladies chroniques. La prévalence croissante des maladies chroniques et non chroniques influence considérablement la croissance du marché des dispositifs d'administration de médicaments. Les maladies chroniques telles que le diabète, les maladies cardiovasculaires et les troubles respiratoires sont de plus en plus répandues, ce qui nécessite des plans de traitement à long terme qui nécessitent des méthodes de distribution de médicaments efficaces et fiables.

  • Croissance dans le développement de dispositifs médicaux biologiques

Les produits biologiques sont considérés comme l'un des segments du marché pharmaceutique connaissant la croissance la plus rapide. Le développement et la fabrication de produits biologiques, qu'il s'agisse de médicaments de marque ou génériques, deviennent de plus en plus compétitifs en raison de la présence de nouveaux acteurs. Les produits biologiques sont généralement administrés par injection dans les bras, les jambes ou l'abdomen. Citons par exemple Cimzia, Cosentyx, Enbrel et Humira, entre autres.

Opportunité

  • Acceptation croissante des dispositifs d'auto-administration de médicaments

L'auto-administration de médicaments par les patients devrait offrir des opportunités de croissance importantes aux acteurs du secteur de l'administration de médicaments qui se concentrent sur le développement de dispositifs innovants et nouveaux. Les principaux facteurs contribuant à cette situation sont l'augmentation de la population âgée, car cette population constitue une base de consommateurs importante pour les dispositifs d'administration de médicaments à domicile. Les sociétés pharmaceutiques se concentrent sur le développement de thérapies conviviales pour les patients et de produits combinés médicament-dispositif auto-administrés. Avec l'acceptation croissante de l'auto-administration, le besoin de produits médicamenteux spécifiques à l'application, par injection, inhalation, topique et transdermique, augmente également.

Retenue/Défi

  • Effets secondaires des systèmes d'administration de médicaments

Adverse reactions to drug delivery systems can lead to a decrease in patient compliance, which can result in decreased demand for the device. This can negatively impact the sales and revenue of the device manufacturer. Side effects can raise concerns about patient safety, leading to increased scrutiny and regulation from regulatory agencies. This can lead to delays in product launches, additional testing requirements, and increased costs for device manufacturers. Moreover, side effects can lead to device rejection by patients, resulting in a decrease in demand for the device. This can be particularly problematic for devices that require long-term use, such as implantable devices.

Recent Developments

  • In August 2023, Janssen Pharmaceutical Companies of Johnson & Johnson Services, Inc. submitted the supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking sanction of DARZALEX in combination with Kyprolis and dexamethasone for relapsed/refractory multiple myeloma. If approved this will increase the product portfolio and also revenue generation of the company
  • In January 2020, Janssen Pharmaceutical Companies of Johnson & Johnson Services, Inc. announced that EC has given the grant to market Erleada which is used to treat metastatic hormone-sensitive prostate cancer (mHSPC) in combination with Androgen Deprivation Therapy (ADT). This will increase their market presence which will further increase the revenue generation
  • In December 2020, Janssen Pharmaceutical Companies of Johnson & Johnson Services, Inc. announced the EC approval of SPRAVATO nasal spray, which will enhance their product portfolio which will further increase the revenue

Europe Drug Delivery Devices Market Scope

The Europe drug delivery devices market is segmented into three notable segments based on product type, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.

Product Type

  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ophthalmic Drug Delivery
  • Nasal Drug Delivery
  • Pulmonary Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery

On the basis of product type, the Europe drug delivery devices market is segmented into injectable drug delivery formulations, injectable drug delivery, topical drug delivery, ophthalmic drug delivery, nasal drug delivery, pulmonary drug delivery, transmucosal drug delivery, and implantable drug delivery.

End User

  • Hospitals
  • Home Healthcare
  • Clinics
  • Community Healthcare
  • Others

On the basis of end user, the Europe drug delivery devices market is segmented into hospitals, home healthcare, clinics, community healthcare and others.

Distribution Channel

  • Direct Tenders
  • Hospital Pharmacies
  • Pharmacy Stores
  • Online Pharmacy

Sur la base du canal de distribution, le marché européen des dispositifs d'administration de médicaments est segmenté en appels d'offres directs, pharmacies hospitalières, pharmacies et pharmacies en ligne.

Analyse/perspectives régionales du marché des dispositifs d'administration de médicaments en Europe

Le marché européen des dispositifs d’administration de médicaments est analysé et des informations sur la taille du marché et les tendances sont fournies en fonction du type de produit, de l’utilisateur final et du canal de distribution, comme référencé ci-dessus.

Les pays couverts dans ce rapport de marché sont l'Allemagne, la France, le Royaume-Uni, l'Italie, l'Espagne, la Russie, les Pays-Bas, la Suisse, la Turquie, la Belgique, le Danemark, la Norvège, la Suède, la Pologne et le reste de l'Europe.

L’Allemagne devrait dominer le marché européen en raison de sa solide base industrielle, de ses investissements importants dans l’innovation en matière de soins de santé et de sa position de leader dans la recherche et le développement en technologie médicale.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces du porteur, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.   

Analyse du paysage concurrentiel et des parts de marché des dispositifs d'administration de médicaments en Europe

Le marché européen des dispositifs d’administration de médicaments est segmenté en trois segments notables en fonction du type de produit, de l’utilisateur final et du canal de distribution.

Le paysage concurrentiel du marché européen des dispositifs d'administration de médicaments fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises sur le marché européen des dispositifs d'administration de médicaments.

Certains des principaux acteurs opérant sur le marché européen des dispositifs d'administration de médicaments sont BD, F. Hoffmann-La Roche Ltd, Novartis AG, Sanofi, Johnson & Johnson Services, Inc., 3M, Gerresheimer AG, Medmix, OraSure Technologies Inc., Insulet Corporation, Bayer AG, Pfizer Inc., GSK plc., Merck & Co., Inc., Amgen Inc., AbbVie Inc., Elcam Medical, SMC Ltd., ViVO Smart Medical Devices Ltd., West et Pharmaceutical Services, Inc. entre autres.


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE DRUG DELIVERY DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET END USER COVERAGE GRID

2.8 PRODUCT TYPE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTERS FIVE FORCES

4.2 PESTEL ANALYSIS

5 REGULATORY FRAMEWORK

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING PREVALENCE OF CHRONIC DISEASE AND NON-CHRONIC DISEASE

6.1.2 GROWTH IN THE DEVELOPMENT OF BIOLOGICS DRUGS DEVICES

6.1.3 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT

6.1.4 INCREASED FOCUS ON PERSONALIZED MEDICINE AND DEVICES

6.2 RESTRAINTS

6.2.1 RISK OF NEEDLE-STICK INJURIES AND SIDE EFFECTS

6.2.2 HIGH COSTS OF INJECTABLE DRUGS

6.2.3 STRINGENT REGULATORY SCENARIO

6.3 OPPORTUNITIES

6.3.1 RISING ACCEPTANCE OF SELF-ADMINISTERING DRUG DEVICES

6.3.2 RISING DEMAND FOR BIOSIMILAR AND GENERIC DRUGS

6.3.3 THERAPEUTIC ADVANCEMENTS IN THE FIELD OF DRUG DELIVERY

6.4 CHALLENGES

6.4.1 SIDE EFFECTS OF DRUG DELIVERY SYSTEMS

6.4.2 INCREASE IN THE NUMBER OF ALTERNATIVES OF DRUG DELIVERY

7 EUROPE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 ORAL DRUG DELIVERY

7.2.1 SOLID ORAL DRUGS

7.2.1.1 TABLETS

7.2.1.2 CAPSULES

7.2.1.3 PILLS

7.2.1.4 POWDERS

7.2.2 LIQUID ORAL DRUGS

7.2.2.1 SYRUPS

7.2.2.2 SOLUTIONS

7.2.3 SEMI SOLID ORAL DRUGS

7.2.3.1 GELS

7.2.3.2 EMULSIONS

7.2.3.3 ELIXIRS

7.3 INJECTABLE DRUG DELIVERY

7.3.1 INJECTABLE DRUG DELIVERY FORMULATIONS

7.3.1.1 CONVENTIONAL DRUG DELIVERY FORMULATIONS

7.3.1.2 NOVEL DRUG DELIVERY FORMULATIONS

7.3.1.3 LONG ACTING INJECTION FORMULATIONS

7.3.2 INJECTABLE DRUG DELIVERY DEVICES

7.3.2.1 CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES

7.3.2.1.1 BY MATERIAL

7.3.2.1.1.1 GLASS

7.3.2.1.1.2 PLASTIC

7.3.2.1.2 BY PRODUCT TYPE

7.3.2.1.2.1 FILLABLE

7.3.2.1.2.2 PRE-FILLED

7.3.2.1.3 BY USABILITY

7.3.2.1.3.1 REUSABLE SYRINGES

7.3.2.1.3.2 DISPOSABLE SYRINGES

7.3.2.2 SELF INJECTION DRUG DELIVERY DEVICES

7.3.2.2.1 NEEDLE FREE INJECTORS

7.3.2.2.2 WEARABLE INJECTORS

7.3.2.2.3 PEN INJECTOR

7.3.2.2.4 AUTO INJECTORS

7.3.2.2.5 OTHERS

7.4 TOPICAL DRUG DELIVERY

7.4.1 TRANSDERMAL DRUG DELIVERY FORMULATIONS

7.4.1.1 SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS

7.4.1.1.1 OINTMENTS

7.4.1.1.2 CREAMS

7.4.1.1.3 LOTIONS

7.4.1.1.4 GELS

7.4.1.1.5 PASTES

7.4.1.2 LIQUID TOPICAL DRUG DELIVERY FORMULATIONS

7.4.1.2.1 SUSPENSIONS

7.4.1.2.2 SOLUTIONS

7.4.1.3 SOLID TOPICAL DRUG DELIVERY FORMULATIONS

7.4.1.3.1 POWDER

7.4.1.3.2 SUPPOSITORS

7.5 OPHTHALMIC DRUG DELIVERY

7.5.1 OCCULAR DRUG DELIVERY FORMULATIONS

7.5.1.1 LIQUID OCCULAR DRUG DELIVERY FORMULATIONS

7.5.1.1.1 SOLUTIONS

7.5.1.1.2 SUSPENSIONS

7.5.1.2 SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS

7.5.1.2.1 GELS

7.5.1.2.2 OINTMENTS

7.5.2 OCCULAR DRUG DELIVERY DEVICES

7.6 NASAL DRUG DELIVERY

7.6.1 NASAL DROPS

7.6.2 NASAL SPRAYS

7.6.3 NASAL POWDERS

7.6.4 NASAL GELS

7.7 PULMONARY DRUG DELIVERY

7.7.1 METERED DOSE INHALERS (MDI)

7.7.2 DRY POWDER INHALERS (DPI)

7.7.3 NEBULIZERS

7.7.3.1 JET NEBULIZERS

7.7.3.2 ULTRASONIC NEBULIZERS

7.7.3.3 SOFT MIST NEBULIZERS

7.8 TRANSMUCOSAL DRUG DELIVERY

7.8.1 ORAL TRANSMUCOSAL DRUG DELIVERY

7.8.1.1 BUCCAL DRUG DELIVERY

7.8.1.2 SUBLINGUAL DRUG DELIVERY

7.8.2 OTHER TRANSMUCOSAL DRUG DELIVERY

7.8.2.1 RECTAL TRANSMUCOSAL DRUG DELIVERY

7.8.2.2 VAGINAL TRANSMUCOSAL DRUG DELIVERY

7.9 IMPLANTABLE DRUG DELIVERY

7.9.1 PASSIVE IMPLANTABLE DRUG DELIVERY DEVICES

7.9.2 ACTIVE IMPLANTABLE DRUG DELIVERY DEVICES

8 EUROPE DRUG DELIVERY DEVICES MARKET, BY END USER

8.1 OVERVIEW

8.2 HOSPITALS

8.3 HOME HEALTHCARE

8.4 CLINICS

8.5 COMMUNITY HEALTHCARE

8.6 OTHERS

9 EUROPE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL

9.1 OVERVIEW

9.2 DIRECT TENDERS

9.3 HOSPITAL PHARMACIES

9.4 PHARMACY STORES

9.5 ONLINE PHARMACY

10 EUROPE DRUG DELIVERY DEVICES MARKET, BY REGION

10.1 EUROPE

10.1.1 GERMANY

10.1.2 FRANCE

10.1.3 ITALY

10.1.4 U.K.

10.1.5 SWITZERLAND

10.1.6 SPAIN

10.1.7 NETHERLANDS

10.1.8 RUSSIA

10.1.9 TURKEY

10.1.10 BELGIUM

10.1.11 REST OF EUROPE

11 EUROPE DRUG DELIVERY DEVICES MARKET: COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: EUROPE

12 SWOT ANALYSIS

13 COMPANY PROFILE

13.1 JOHNSON & JOHNSON SERVICES, INC.

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 COMPANY SHARE ANALYSIS

13.1.4 PRODUCT PORTFOLIO

13.1.5 RECENT DEVELOPMENTS

13.2 NOVARTIS AG

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 COMPANY SHARE ANALYSIS

13.2.4 PRODUCT PORTFOLIO

13.2.5 RECENT DEVELOPMENTS

13.3 F. HOFFMANN-LA ROCHE LTD

13.3.1 COMPANY SNAPSHOT

13.3.2 REVENUE ANALYSIS

13.3.3 COMPANY SHARE ANALYSIS

13.3.4 PRODUCT PORTFOLIO

13.3.5 RECENT DEVELOPMENT

13.4 BAYER AG

13.4.1 COMPANY SNAPSHOT

13.4.2 REVENUE ANALYSIS

13.4.3 COMPANY SHARE ANALYSIS

13.4.4 PRODUCT PORTFOLIO

13.5 PFIZER INC.

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 COMPANY SHARE ANALYSIS

13.5.4 PRODUCT PORTFOLIO

13.5.5 RECENT DEVELOPMENT

13.6 3M

13.6.1 COMPANY SNAPSHOT

13.6.2 REVENUE ANALYSIS

13.6.3 PRODUCT PORTFOLIO

13.6.4 RECENT DEVELOPMENTS

13.7 ABBVIE INC.

13.7.1 COMPANY SNAPSHOT

13.7.2 REVENUE ANALYSIS

13.7.3 PRODUCT PORTFOLIO

13.7.4 RECENT DEVELOPMENTS

13.8 AMGEN INC.

13.8.1 COMPANY SNAPSHOT

13.8.2 REVENUE ANALYSIS

13.8.3 PRODUCT PORTFOLIO

13.8.4 RECENT DEVELOPMENTS

13.9 BD

13.9.1 COMPANY SNAPSHOT

13.9.2 REVENUE ANALYSIS

13.9.3 PRODUCT PORTFOLIO

13.9.4 RECENT DEVELOPMENT

13.1 ELCAM MEDICAL

13.10.1 COMPANY SNAPSHOT

13.10.2 PRODUCT PORTFOLIO

13.10.3 RECENT DEVELOPMENT

13.11 ENABLE INJECTIONS

13.11.1 COMPANY SNAPSHOT

13.11.2 PRODUCT PORTFOLIO

13.11.3 RECENT DEVELOPMENTS

13.12 GERRESHEIMER AG

13.12.1 COMPANY SNAPSHOT

13.12.2 REVENUE ANALYSIS

13.12.3 PRODUCT PORTFOLIO

13.12.4 RECENT DEVELOPMENTS

13.13 GSK PLC.

13.13.1 COMPANY SNAPSHOT

13.13.2 REVENUE ANALYSIS

13.13.3 PRODUCT PORTFOLIO

13.13.4 RECENT DEVELOPMENTS

13.14 INSULET CORPORATION

13.14.1 COMPANY SNAPSHOT

13.14.2 REVENUE ANALYSIS

13.14.3 PRODUCT PORTFOLIO

13.14.4 RECENT DEVELOPMENTS

13.15 MEDMIX

13.15.1 COMPANY SNAPSHOT

13.15.2 REVENUE ANALYSIS

13.15.3 PRODUCT PORTFOLIO

13.15.4 RECENT DEVELOPMENTS

13.16 MERCK & CO., INC.

13.16.1 COMPANY SNAPSHOT

13.16.2 REVENUE ANALYSIS

13.16.3 PRODUCT PORTFOLIO

13.16.4 RECENT DEVELOPMENT

13.17 ORASURE TECHNOLOGIES INC.

13.17.1 COMPANY SNAPSHOT

13.17.2 REVENUE ANALYSIS

13.17.3 PRODUCT PORTFOLIO

13.17.4 RECENT DEVELOPMENT

13.18 SANOFI

13.18.1 COMPANY SNAPSHOT

13.18.2 REVENUE ANALYSIS

13.18.3 PRODUCT PORTFOLIO

13.18.4 RECENT DEVELOPMENTS

13.19 SMC LTD.

13.19.1 COMPANY SNAPSHOT

13.19.2 REVENUE ANALYSIS

13.19.3 PRODUCT PORTFOLIO

13.19.4 RECENT DEVELOPMENTS

13.2 VIVO SMART MEDICAL DEVICES LTD.

13.20.1 COMPANY SNAPSHOT

13.20.2 PRODUCT PORTFOLIO

13.20.3 RECENT DEVELOPMENT

13.21 WEST PHARMACEUTICAL SERVICES, INC.

13.21.1 COMPANY SNAPSHOT

13.21.2 REVENUE ANALYSIS

13.21.3 PRODUCT PORTFOLIO

13.21.4 RECENT DEVELOPMENT

14 QUESTIONNAIRE

15 RELATED REPORTS

Liste des tableaux

TABLE 1 LIST OF FDA APPROVED BIOLOGICS, IN 2022

TABLE 2 10 MOST EXPENSIVE DRUGS IN THE U.S. (IN USD MILLION)

TABLE 3 EUROPE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 4 EUROPE ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 5 EUROPE ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 6 EUROPE SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 7 EUROPE LIQUID ORAL DRUG IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 8 EUROPE SEMI SOLID ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 9 EUROPE INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 10 EUROPE INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 11 EUROPE INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 12 EUROPE INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 13 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 14 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE 2022-2031 (USD MILLION)

TABLE 15 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 16 EUROPE SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 17 EUROPE TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 18 EUROPE TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 19 EUROPE TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 20 EUROPE SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 21 EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 22 EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 23 EUROPE OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 24 EUROPE OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 25 EUROPE OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 26 EUROPE LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 27 EUROPE SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 28 EUROPE NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 29 EUROPE NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 30 EUROPE PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 31 EUROPE TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 32 EUROPE NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 33 EUROPE TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 34 EUROPE TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 35 EUROPE ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 36 EUROPE OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 37 EUROPE IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 38 EUROPE TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 39 EUROPE DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 40 EUROPE HOSPITALS IN DRUG DELIVERY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 41 EUROPE HOME HEALTHCARE IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 42 EUROPE CLINICS IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 43 EUROPE COMMUNITY HEALTHCARE IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 44 EUROPE OTHERS IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 45 EUROPE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 46 EUROPE DIRECT TENDERS IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 47 EUROPE HOSPITAL PHARMACIES IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 48 EUROPE PHARMACY STORES IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 49 EUROPE ONLINE PHARMACY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 50 EUROPE DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 51 EUROPE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 52 EUROPE ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 53 EUROPE SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 54 EUROPE LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 55 EUROPE SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 56 EUROPE INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 57 EUROPE INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 58 EUROPE INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 59 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 60 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 61 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 62 EUROPE SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 63 EUROPE TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 64 EUROPE TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 65 EUROPE SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 66 EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 67 EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 68 EUROPE OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 69 EUROPE OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 70 EUROPE LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 71 EUROPE SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 72 EUROPE NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 73 EUROPE PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 74 EUROPE NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 75 EUROPE TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 76 EUROPE ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 77 EUROPE OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 78 EUROPE IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 79 EUROPE DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 80 EUROPE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 81 GERMANY DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 82 GERMANY ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 83 GERMANY SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 84 GERMANY LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 85 GERMANY SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 86 GERMANY INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 87 GERMANY INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 88 GERMANY INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 89 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 90 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 91 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 92 GERMANY SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 93 GERMANY TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 94 GERMANY TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 95 GERMANY SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 96 GERMANY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 97 GERMANY SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 98 GERMANY OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 99 GERMANY OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 100 GERMANY LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 101 GERMANY SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 102 GERMANY NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 103 GERMANY PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 104 GERMANY NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 105 GERMANY TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 106 GERMANY ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 107 GERMANY OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 108 GERMANY IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 109 GERMANY DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 110 GERMANY DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 111 FRANCE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 112 FRANCE ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 113 FRANCE SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 114 FRANCE LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 115 FRANCE SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 116 FRANCE INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 117 FRANCE INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 118 FRANCE INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 119 FRANCE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 120 FRANCE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 121 FRANCE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 122 FRANCE SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 123 FRANCE TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 124 FRANCE TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 125 FRANCE SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 126 FRANCE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 127 FRANCE SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 128 FRANCE OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 129 FRANCE OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 130 FRANCE LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 131 FRANCE SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 132 FRANCE NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 133 FRANCE PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 134 FRANCE NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 135 FRANCE TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 136 FRANCE ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 137 FRANCE OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 138 FRANCE IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 139 FRANCE DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 140 FRANCE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 141 ITALY DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 142 ITALY ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 143 ITALY SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 144 ITALY LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 145 ITALY SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 146 ITALY INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 147 ITALY INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 148 ITALY INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 149 ITALY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 150 ITALY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 151 ITALY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 152 ITALY SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 153 ITALY TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 154 ITALY TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 155 ITALY SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 156 ITALY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 157 ITALY SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 158 ITALY OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 159 ITALY OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 160 ITALY LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 161 ITALY SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 162 ITALY NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 163 ITALY PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 164 ITALY NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 165 ITALY TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 166 ITALY ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 167 ITALY OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 168 ITALY IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 169 ITALY DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 170 ITALY DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 171 U.K. DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 172 U.K. ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 173 U.K. SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 174 U.K. LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 175 U.K. SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 176 U.K. INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 177 U.K. INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 178 U.K. INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 179 U.K. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 180 U.K. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 181 U.K. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 182 U.K. SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 183 U.K. TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 184 U.K. TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 185 U.K. SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 186 U.K. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 187 U.K. SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 188 U.K. OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 189 U.K. OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 190 U.K. LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 191 U.K. SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 192 U.K. NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 193 U.K. PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 194 U.K. NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 195 U.K. TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 196 U.K. ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 197 U.K. OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 198 U.K. IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 199 U.K. DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 200 U.K. DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 201 SWITZERLAND DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 202 SWITZERLAND ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 203 SWITZERLAND SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 204 SWITZERLAND LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 205 SWITZERLAND SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 206 SWITZERLAND INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 207 SWITZERLAND INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 208 SWITZERLAND INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 209 SWITZERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 210 SWITZERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 211 SWITZERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 212 SWITZERLAND SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 213 SWITZERLAND TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 214 SWITZERLAND TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 215 SWITZERLAND SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 216 SWITZERLAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 217 SWITZERLAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 218 SWITZERLAND OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 219 SWITZERLAND OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 220 SWITZERLAND LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 221 SWITZERLAND SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 222 SWITZERLAND NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 223 SWITZERLAND PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 224 SWITZERLAND NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 225 SWITZERLAND TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 226 SWITZERLAND ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 227 SWITZERLAND OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 228 SWITZERLAND IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 229 SWITZERLAND DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 230 SWITZERLAND DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 231 SPAIN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 232 SPAIN ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 233 SPAIN SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 234 SPAIN LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 235 SPAIN SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 236 SPAIN INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 237 SPAIN INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 238 SPAIN INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 239 SPAIN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 240 SPAIN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 241 SPAIN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 242 SPAIN SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 243 SPAIN TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 244 SPAIN TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 245 SPAIN SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 246 SPAIN LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 247 SPAIN SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 248 SPAIN OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 249 SPAIN OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 250 SPAIN LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 251 SPAIN SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 252 SPAIN NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 253 SPAIN PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 254 SPAIN NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 255 SPAIN TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 256 SPAIN ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 257 SPAIN OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 258 SPAIN IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 259 SPAIN DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 260 SPAIN DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 261 NETHERLANDS DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 262 NETHERLANDS ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 263 NETHERLANDS SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 264 NETHERLANDS LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 265 NETHERLANDS SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 266 NETHERLANDS INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 267 NETHERLANDS INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 268 NETHERLANDS INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 269 NETHERLANDS CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 270 NETHERLANDS CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 271 NETHERLANDS CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 272 NETHERLANDS SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 273 NETHERLANDS TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 274 NETHERLANDS TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 275 NETHERLANDS SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 276 NETHERLANDS LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 277 NETHERLANDS SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 278 NETHERLANDS OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 279 NETHERLANDS OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 280 NETHERLANDS LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 281 NETHERLANDS SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 282 NETHERLANDS NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 283 NETHERLANDS PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 284 NETHERLANDS NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 285 NETHERLANDS TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 286 NETHERLANDS ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 287 NETHERLANDS OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 288 NETHERLANDS IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 289 NETHERLANDS DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 290 NETHERLANDS DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 291 RUSSIA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 292 RUSSIA ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 293 RUSSIA SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 294 RUSSIA LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 295 RUSSIA SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 296 RUSSIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 297 RUSSIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 298 RUSSIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 299 RUSSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 300 RUSSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 301 RUSSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 302 RUSSIA SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 303 RUSSIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 304 RUSSIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 305 RUSSIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 306 RUSSIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 307 RUSSIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 308 RUSSIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 309 RUSSIA OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 310 RUSSIA LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 311 RUSSIA SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 312 RUSSIA NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 313 RUSSIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 314 RUSSIA NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 315 RUSSIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 316 RUSSIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 317 RUSSIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 318 RUSSIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 319 RUSSIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 320 RUSSIA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 321 TURKEY DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 322 TURKEY ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 323 TURKEY SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 324 TURKEY LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 325 TURKEY SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 326 TURKEY INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 327 TURKEY INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 328 TURKEY INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 329 TURKEY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 330 TURKEY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 331 TURKEY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 332 TURKEY SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 333 TURKEY TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 334 TURKEY TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 335 TURKEY SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 336 TURKEY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 337 TURKEY SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 338 TURKEY OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 339 TURKEY OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 340 TURKEY LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 341 TURKEY SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 342 TURKEY NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 343 TURKEY PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 344 TURKEY NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 345 TURKEY TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 346 TURKEY ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 347 TURKEY OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 348 TURKEY IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 349 TURKEY DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 350 TURKEY DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 351 BELGIUM DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 352 BELGIUM ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 353 BELGIUM SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 354 BELGIUM LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 355 BELGIUM SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 356 BELGIUM INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 357 BELGIUM INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 358 BELGIUM INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 359 BELGIUM CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 360 BELGIUM CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 361 BELGIUM CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 362 BELGIUM SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 363 BELGIUM TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 364 BELGIUM TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 365 BELGIUM SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 366 BELGIUM LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 367 BELGIUM SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 368 BELGIUM OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 369 BELGIUM OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 370 BELGIUM LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 371 BELGIUM SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 372 BELGIUM NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 373 BELGIUM PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 374 BELGIUM NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 375 BELGIUM TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 376 BELGIUM ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 377 BELGIUM OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 378 BELGIUM IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 379 BELGIUM DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 380 BELGIUM DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 381 REST OF EUROPE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

Liste des figures

FIGURE 1 EUROPE DRUG DELIVERY DEVICES MARKET: SEGMENTATION

FIGURE 2 EUROPE DRUG DELIVERY DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE DRUG DELIVERY DEVICES MARKET: DROC ANALYSIS

FIGURE 4 EUROPE DRUG DELIVERY DEVICES MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE DRUG DELIVERY DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE DRUG DELIVERY DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE DRUG DELIVERY DEVICES MARKET: MARKET END USER COVERAGE GRID

FIGURE 8 EUROPE DRUG DELIVERY DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE DRUG DELIVERY DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE DRUG DELIVERY DEVICES MARKET: SEGMENTATION

FIGURE 11 EXECUTIVE SUMMARY

FIGURE 12 EIGHT SEGMENTS COMPRISE THE EUROPE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 RISING PREVALENCE OF CHRONIC DISEASE AND NON-CHRONIC DISEASE ARE DRIVING THE GROWTH OF THE EUROPE DRUG DELIVERY DEVICES MARKET FROM 2024 TO 2031

FIGURE 15 THE ORAL DRUG DELIVERY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE DRUG DELIVERY DEVICES MARKET IN 2024 AND 2031

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE DRUG DELIVERY DEVICES MARKET

FIGURE 17 EUROPE DRUG DELIVERY DEVICES MARKET: BY PRODUCT TYPE, 2023

FIGURE 18 EUROPE DRUG DELIVERY DEVICES MARKET: BY PRODUCT TYPE, 2023-2031 (USD MILLION)

FIGURE 19 EUROPE DRUG DELIVERY DEVICES MARKET: BY PRODUCT TYPE, CAGR (2024-2031)

FIGURE 20 EUROPE DRUG DELIVERY DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 21 EUROPE DRUG DELIVERY MARKET: BY END USER, 2023

FIGURE 22 EUROPE DRUG DELIVERY DEVICES MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 23 EUROPE DRUG DELIVERY DEVICES MARKET: END USER, CAGR (2024-2031)

FIGURE 24 EUROPE DRUG DELIVERY DEVICES MARKET: END USER, LIFELINE CURVE

FIGURE 25 EUROPE DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2023

FIGURE 26 EUROPE DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)

FIGURE 27 EUROPE DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)

FIGURE 28 EUROPE DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 29 EUROPE DRUG DELIVERY DEVICES MARKET: SNAPSHOT (2023)

FIGURE 30 EUROPE DRUG DELIVERY DEVICES MARKET: COMPANY SHARE 2023 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The market is segmented based on , By Product Type (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ophthalmic Drug Delivery, Nasal Drug Delivery, Pulmonary Drug Delivery, Transmucosal Drug Delivery, and Implantable Drug Delivery), End User (Hospitals, Home Healthcare, Clinics, Community Healthcare and Others), Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, and Online Pharmacy) - Industry Trends and Forecast to 2031. .
The Europe Drug Delivery Devices Market size was valued at USD 497.13 USD Billion in 2023.
The Europe Drug Delivery Devices Market is projected to grow at a CAGR of 7.5% during the forecast period of 2024 to 2031.
The market report covers data from the Germany, U.K., Italy, France, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands, and rest of Europe,.